Investing tools

DCF calculator for Indian stocks

Pick a company, see the growth its price already assumes, then change the assumptions and watch the fair value move.

Showing HCL Technologies. See HCL Technologies company page →

What the price assumes

Fair

To justify its price of ₹1420, this stock must grow earnings at 5% every year for 5 years. Our analysis caps realistic growth at ~4%. At that growth it is worth ₹1335 — downside of 6%.

Growth the price implies: 5.2% a year; for 5 years, fading to 5%
It has actually compounded at: 3.9% a year; net profit, FY23–FY26 · EPS 3.9%
The gap: 0.0 pp; -6% downside if it only repeats history

Price today ₹1,420 Value at the reference growth ₹1,334.51

Why this baseline, and what it is built on

HCLTech demonstrates a strong promise track record, with multiple achieved targets and upward revisions to guidance. Management recently revised up their full-year company-level revenue growth guidance to 4% to 4.5% for FY26. Although the latest TTM sales growth is 2.95%, the strong track record and explicit, revised-up guidance support using the lower end of this range for g1 at 4.0%. The company has very low leverage, leading to a 10% discount rate. A 5-year stage-1 growth period with a 3-year fade to a 5% terminal growth rate is considered appropriate.

Through 2026-03-31

Your assumptions

Change any of these and the value moves. A valuation that flips on a one-point change in the required return is telling you something.

Growth 4% a year, stage oneFor 5 yrs before it fadesFading over 3 yrs to terminalTerminal 5% capped at 6%Required return 10% your hurdle

Value on these assumptions

₹1,334.43

Against today's price

-6%

8 projected years, then a terminal value at 5.0%.

Normalized net profit is discounted as a proxy for owner earnings, not full free cash flow. An analytical tool, not investment advice.

How to read this valuation

Start from the price, not the forecast. A normal DCF asks you to guess growth and hands back a fair value. Run backwards, it takes today's price and solves for the earnings growth the market is already assuming.
Compare that with what the company has done. The historical profit and EPS CAGR sit beside the implied number. A price that needs 25% a year from a business that has compounded at 10% is asking a lot, and the gap is the risk you are taking on.
Then apply your own view. Change the growth rate, how long it lasts, how it fades and the return you require. A valuation that flips on a one-point change in the discount rate is telling you something about itself.
Mind the caveats. Normalized net profit stands in for owner earnings, not full free cash flow; terminal growth is capped at 6%, roughly nominal GDP; cyclicals are flagged because a peak-earnings base overstates value. This is an analytical tool, not investment advice.